Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis

This publication has 45 references indexed in Scilit:

• Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): Review from an international consensus conference
  Pediatric Blood & Cancer, 2010
• Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program
  Molecular Cancer Therapeutics, 2010
• Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group Report
  Leukemia, 2009
• Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
  British Journal of Cancer, 2009
• PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
  Journal of Clinical Investigation, 2008
• mTORC1 promotes survival through translational control of Mcl-1
  Proceedings of the National Academy of Sciences, 2008
• Low‐dose, single‐agent temsirolimus for relapsed mantle cell lymphoma
  Cancer, 2008
• mTOR and cancer: insights into a complex relationship
  Nature Reviews Cancer, 2006
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
  Nature Reviews Genetics, 2006
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
  Science, 2005